Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349656 (2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349659 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]-3-flu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 350 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349662 (2-{[4-(6-{[(4-cyano-2-fluorophenyl)(methyl-d2)]oxy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | n/a | n/a | 0.950 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349669 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349670 (2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}pip...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349673 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 44 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349674 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 75 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349676 (US10208019, Example 1A-23 | rac-2-{[(3S,4S)-4-{6-[...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349680 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349691 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349693 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 680 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349695 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 340 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349701 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349706 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349709 (2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.40 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349710 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.760 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349711 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349716 (2-((4-(6-(Benzyloxy)pyridin-2-yl)piperidin-1-yl)me...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349724 (1-methyl-2-{[4-(6-{[4-(trifluoromethoxy)benzyl]oxy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 880 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349729 (2-[(4-{6-[(2,5-difluorobenzyl)oxy]pyridin-2-yl}pip...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349732 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349735 (2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}pip...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349742 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.40E+3 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349743 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349746 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349748 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349750 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.50E+4 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349755 (2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 41 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349761 (2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}pip...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 59 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349764 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349765 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349766 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.330 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349767 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349772 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349773 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349785 (2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349789 (2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349794 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349797 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349798 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 140 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349804 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349805 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.950 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349806 (2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349810 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349814 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349828 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349833 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 28 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349833 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 450 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349834 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 360 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349842 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 96 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 434 total ) | Next | Last >> |